Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions
10.1038/sj.onc.1207439
Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Sarrió, D., Pérez-Mies, B., Hardisson, D., Moreno-Bueno, G., Suárez, A., Cano, A., Martín-Pérez, J., Gamallo, C., & Palacios, J. (2004). Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene, 23(19), 3272–3283.

Authors 9
  1. David Sarrió (first)
  2. Belén Pérez-Mies (additional)
  3. David Hardisson (additional)
  4. Gema Moreno-Bueno (additional)
  5. Asunción Suárez (additional)
  6. Amparo Cano (additional)
  7. Jorge Martín-Pérez (additional)
  8. Carlos Gamallo (additional)
  9. José Palacios (additional)
References 44 Referenced 168
  1. Aho S, Levänsuo L, Montonen O, Karl C, Rodeck U and Uitto J . (2002). J. Cell Sci., 115, 1391–1402. (10.1242/jcs.115.7.1391)
  2. Anastasiadis PZ and Reynolds AB . (2000). J. Cell Sci., 113, 1319–1334. (10.1242/jcs.113.8.1319)
  3. Anastasiadis PZ and Reynolds AB . (2001). Curr. Opin. Cell Biol., 13, 604–610. (10.1016/S0955-0674(00)00258-1)
  4. Anastasiadis PZ, Moon SY, Thorenson MA, Mariner DJ, Crawford HC, Zheng Y and Reynolds AB . (2000). Nat. Cell Biol., 2, 637–644. (10.1038/35023588)
  5. Beavon IRG . (2000). Eur. J. Cancer, 36, 1607–1620. (10.1016/S0959-8049(00)00158-1)
  6. Berx G, Becker KF, Höfler H and van Roy F . (1998). Hum. Mutat., 12, 226–237. (10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D)
  7. Bolos V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M and Cano A . (2003). J. Cell Sci., 116, 499–511. (10.1242/jcs.00224)
  8. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA . (2000). Nat. Cell Biol., 2, 76–83. (10.1038/35000025)
  9. Christofori G and Semb H . (1999). Trends Biochem. Sci., 24, 73–76. (10.1016/S0968-0004(98)01343-7)
  10. Conacci-Sorrell M, Zhurinsky J and Ben-Ze'ev A . (2002). J. Clin. Invest., 109, 987–991. (10.1172/JCI0215429)
  11. Daniel JM and Reynolds AB . (1995). Mol. Cell. Biol., 15, 4819–4824. (10.1128/MCB.15.9.4819)
  12. Daniel JM and Reynolds AB . (1997). BioEssays, 19, 883–891. (10.1002/bies.950191008)
  13. Daniel JM and Reynolds AB . (1999). Mol. Cell. Biol., 19, 3614–3623. (10.1128/MCB.19.5.3614)
  14. Dillon D, D'Aquila T, Reynolds AB, Fearon ER and Rimm DL . (1998). Am. J. Pathol., 152, 75–82.
  15. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I and Hart IR . (2001). Int. J. Cancer, 92, 404–408. (10.1002/ijc.1208)
  16. Fresno Vara J, Carretero M.V, Gerónimo H, Ballmer-Hofer K and Martín J . (2000). Biochem. J., 345, 17–24. (10.1042/bj3450017)
  17. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A . (1993). Am. J. Pathol., 142, 983–987.
  18. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB . (1995). Cancer Res., 55, 5195–5199.
  19. Husmark J, Heldin NE and Nilsson M . (1999). Int. J. Cancer, 83, 692–699. (10.1002/(SICI)1097-0215(19991126)83:5<692::AID-IJC21>3.0.CO;2-1)
  20. Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, Anastasiadis PZ, Matrisian L, Bundy LM, Sealy L, Gilbert B, van Roy F and Reynolds AB . (2002). J. Cell Biol., 159, 465–476. (10.1083/jcb.200205115)
  21. Jawhari AU, Noda M, Pignatelli M and Farthing M . (1999). J. Pathol., 189, 180–185. (10.1002/(SICI)1096-9896(199910)189:2<180::AID-PATH414>3.0.CO;2-2)
  22. Jiang WG and Mansel RE . (2000). Surg. Oncol., 9, 151–171. (10.1016/S0960-7404(01)00010-X)
  23. Keiserbilck A, Bonne S, Staes J, van Hengel F, Nollet A, Reynolds A and van Roy F . (1998). Genomics, 50, 129–146. (10.1006/geno.1998.5325)
  24. Kohy N, Kitajima Y, Jiao W and Miyazaki K . (2002). Int. J. Cancer, 104, 44–53. (10.1002/ijc.10920)
  25. Lishman SC and Lakhani SR . (1999). Histopathology, 35, 195–200. (10.1046/j.1365-2559.1999.00815.x)
  26. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA and Shipley JM . (1998). Cancer Res., 58, 4721–4727.
  27. Mariner DJ, Anastasiadis P, Keilhack H, Böhmer FD, Wang J and Reynolds A . (2001). J. Biol. Chem., 276, 28006–28013. (10.1074/jbc.M102443200)
  28. Mayerle J, Friess H, Buchler MW, Schnekenburger J, Weiss FU, Zimmer KP, Domschke W and Lerch MM . (2003). Gastroenterology, 124, 949–960. (10.1053/gast.2003.50142)
  29. Mo YY and Reynolds AB . (1996). Cancer Res., 56, 2633–2640.
  30. Montonen O, Aho M, Uitto J and Aho S . (2001). J. Histochem. Cytochem., 49, 1487–1495. (10.1177/002215540104901202)
  31. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M and Palacios J . (2002). Oncogene, 21, 7981–7990. (10.1038/sj.onc.1205924)
  32. Nagafuchi A . (2001). Curr. Opin. Cell Biol., 13, 600–603. (10.1016/S0955-0674(00)00257-X)
  33. Nakapoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P and Pignatelli M . (2002). Histopathology, 40, 536–546. (10.1046/j.1365-2559.2002.01392.x)
  34. Ozawa M and Ohkubo T . (2001). J. Cell Sci., 114, 503–512. (10.1242/jcs.114.3.503)
  35. Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA and Cano A . (2001). J. Biol. Chem., 276, 27424–27431. (10.1074/jbc.M100827200)
  36. Prokhortchouc A, Hendrich B, Jornsen H, Ruzov A, Wilm M, Georgiev G, Bird A and Prokhortchouc E . (2001). Genes Dev., 15, 1613–1618. (10.1101/gad.198501)
  37. Reynolds AB, Herbert L, Cleveland JL, Berg ST and Gaut JR . (1992). Oncogene, 7, 2439–2445.
  38. Roura S, Miravet S, Piedra J, García de Herreros A and Duñach M . (1999). J. Biol. Chem., 274, 36734–36740. (10.1074/jbc.274.51.36734)
  39. Sarrió D, Moreno-Bueno G, Hardisson D, Sánchez-Estévez C, Guo M, Herman JG, Gamallo C, Esteller M and Palacios J . (2003). Int. J. Cancer, 106, 208–215. (10.1002/ijc.11197)
  40. Thoreson MA and Reynolds AB . (2002). Differentiation, 70, 583–589. (10.1046/j.1432-0436.2002.700911.x)
  41. Thoreson MA, Anastasiadis PZ, Daniel JM, Ireton RC, Wheelock MJ, Johnson KR, Hummingbird DK and Reynolds AB . (2000). J. Cell Biol., 148, 189–201. (10.1083/jcb.148.1.189)
  42. Tomita K, van Bokhoven A, van Leenders G, Ruijter ETG, Jansen CFJ, Bussemakers MJG and Schalken JA . (2000). Cancer Res., 60, 3650–3654.
  43. Tran NL, Nagle RB, Cress AE and Heimark RL . (1999). Am. J. Pathol., 155, 787–798. (10.1016/S0002-9440(10)65177-2)
  44. Van Hengel J, Vanhoenacker P, Staes K and van Roy F . (1999). Proc. Natl. Acad. Sci. USA, 96, 7980–7985. (10.1073/pnas.96.14.7980)
Dates
Type When
Created 21 years, 4 months ago (April 12, 2004, 6:08 a.m.)
Deposited 3 years, 5 months ago (March 21, 2022, 11:44 p.m.)
Indexed 2 months, 1 week ago (June 23, 2025, 4:02 p.m.)
Issued 21 years, 4 months ago (April 12, 2004)
Published 21 years, 4 months ago (April 12, 2004)
Published Online 21 years, 4 months ago (April 12, 2004)
Published Print 21 years, 4 months ago (April 22, 2004)
Funders 0

None

@article{Sarri__2004, title={Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions}, volume={23}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1207439}, DOI={10.1038/sj.onc.1207439}, number={19}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Sarrió, David and Pérez-Mies, Belén and Hardisson, David and Moreno-Bueno, Gema and Suárez, Asunción and Cano, Amparo and Martín-Pérez, Jorge and Gamallo, Carlos and Palacios, José}, year={2004}, month=apr, pages={3272–3283} }